---
$id: https://graph.org.ai/products/commodity/51131631
$type: Product
source: UNSPSC
code: "51131631"
title: "Dabigatran"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dabigatran

**UNSPSC Code**: 51131631
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0VM4M70GC. European Medicines Agency schedules Dabigatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25417. Dabigatran generally arises in the molecular formula C25H25N7O3. The term DABIGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46.) Most nations schedule dabigatran under HS 29333999 and SITC 51574. As of Q4 2014, DABIGATRAN remains the US FDA Preferred Term for this commodity. Dabigatran bears US NLM identifiers UMLS ID C2348066 and NCI Concept Code C73224. SMILES: O=C(N(CCC(=O)O)C1NCCCC1)C1CC2NC(N(C2CC1)C)CNC1CCC(CC1)C(=N)N.

